Diabetes decisions — 2024

The Board has determined that the decision on appeal is November 2019 and not April 2020, as the April 2020 rating decision did not adjudicate the DIC claim. The AOJ must now make a finding regarding whether the Appellant is considered the surviving child of the Veteran and provide complete notice of the decision under 38 U.S.C. § 5104. A VA examination should be afforded to the Appellant to determine if the cause of death is related to service or toxic exposure.

The Veteran's appeals for service connection for diabetes and a lung problem have been dismissed due to the death of the Veteran.

The Veteran's appeals for service connection were dismissed due to his withdrawal of the appeal.

The Board has determined that the severance of service connection for type 2 diabetes mellitus, diabetic nephropathy, and bilateral lower extremity neuropathy was improper due to herbicide exposure in Thailand. The appeal is granted.

The Board has dismissed the Veteran's claim for service connection for head trauma with scarring due to his withdrawal request. The Board has also remanded the issue of service connection for diabetes mellitus, as new and relevant evidence has been received.

The Veteran's appeals for service connection were dismissed due to the withdrawal of his appeal by his representative.

The Veteran's claims for increased ratings, service connection, and secondary service connection are being remanded due to errors in the duty to assist.

The Board has decided to remand several issues related to the Veteran's service-connected disabilities, including effective date claims and disability evaluation requests. The appellant is seeking clarification on when certain benefits were awarded or should have been awarded.

The Board denied the Veteran's claim for service connection for diabetes mellitus, type II due to a lack of current diagnosis and conflicting evidence regarding whether the Veteran has this condition.

The Veteran's claim for a bilateral hearing loss disability is denied as he does not have a current disability for VA purposes.,The Veteran's claims for an acquired psychiatric disorder, diabetes mellitus, peripheral neuropathy (upper and lower extremities), erectile dysfunction, vestibular disability, skin condition, heart condition, and respiratory condition are remanded due to the need for further development of evidence.,The Veteran's claim for a bilateral kidney condition is remanded as it may be related to his service-connected diabetes mellitus.

The Veteran claims that her diabetes mellitus, type II is related to her military service, specifically exposure to Agent Orange. The RO denied the claim without scheduling a VA examination, which may have been necessary due to potential exposure at Fort McClellan.

The Veteran's diabetes mellitus type II, gastroparesis, and peripheral neuropathies have been granted ratings. The Veteran has also been awarded a TDIU and SMC based on need for aid and attendance.

The Veteran's claim for a higher rating for bilateral eye disability was denied. The issue of service connection for bilateral cataracts as secondary to Type II diabetes mellitus is dismissed. Service connection for an ulcer of the right great toe is granted, and SMC based on need for regular aid and attendance is awarded.

The Board denied the appellant's claim for DIC benefits based on her being recognized as a helpless child of the deceased Veteran due to permanent incapacity for self-support prior to reaching the age of 18, finding insufficient evidence to support this claim.

The Board has decided to remand the Veteran's claims for service connection for hypertension and diabetes mellitus type II (DMII) due to insufficient rationale in the VA examiner's opinions. The AOJ is instructed to obtain clarifying addendum opinions addressing direct and secondary service-connection.

The Veteran's claims for service connection of myocardial infarction and diabetes mellitus type II were granted with effective dates of February 21, 2019, and February 21, 2018, respectively. The earlier effective date was determined based on the liberalizing laws that allowed retroactive benefits.

The Board denied the Veteran's claim for an earlier effective date of January 14, 2013, for a 40 percent rating for diabetes mellitus type II. The evidence showed that the increase in disability occurred after the claim was filed and thus the earliest possible effective date is January 14, 2013.

The Board has determined that new and relevant evidence has been submitted regarding the Veteran's claim of diabetes mellitus, which is presumed to be related to Agent Orange exposure. The AOJ must now readjudicate this claim.

The Veteran's service-connected disabilities render him unable to secure and follow a substantially gainful occupation, as his bilateral lower extremity peripheral neuropathy limits his ability to perform physical tasks required for sedentary employment.

The Board found no evidence of a service-connected condition and concluded that the Veteran's type II diabetes mellitus did not have its onset during active duty or is otherwise related to service.